Tom Wagemans

Genistein in Sanfilippo disease: A randomized controlled crossover trial

Jessica de Ruijter, M. J. Valstar, Magdalena Narajczyk et al. · Annals of Neurology · 2011 · 111 citations · Full text

Life Sciences, Biochemistry, Pharmacotherapy +13

Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III

Jessica de Ruijter, Minke H. de Ru, Tom Wagemans et al. · Molecular Genetics and Metabolism · 2012 · 105 citations

Life Sciences, Biochemistry, Clinical Biochemistry +8

A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids

Carlo W.T. van Roermund, Lodewijk IJlst, Tom Wagemans et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2013 · 102 citations

Life Sciences, Biochemistry, Molecular Biology +14

Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy

Eveline J. Langereis, Naomi van Vlies, Heather J. Church et al. · Molecular Genetics and Metabolism · 2014 · 60 citations

Life Sciences, Clinical Sciences, Immunology +11

Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long‐term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans

Minke H. de Ru, Linda van der Tol, Naomi van Vlies et al. · Journal of Inherited Metabolic Disease · 2012 · 48 citations · Full text

Life Sciences, Biochemistry, Pharmacokinetics +14